B-Cell Lymphomas Coverage from Every Angle

Leo I. Gordon, MD, on the Debate Over Prophylaxis for Central Nervous System Relapse in DLBCL

Posted: Thursday, February 10, 2022

Leo I. Gordon, MD, of Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, talks about what to do for patients with diffuse large B-cell lymphoma (DLBCL) who are at risk of central nervous system relapse and whether prophylactic measures make any difference.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.